Literature DB >> 2035776

The neuromuscular blocking effect of Org 9426. A new intermediately-acting steroidal non-depolarising muscle relaxant in man.

L H Booij1, H T Knape.   

Abstract

Org 9426, a new steroidal non-depolarising muscle relaxant, which is stable in solution, was studied in 30 anaesthetised (thiopentone, fentanyl, nitrous oxide) male patients, ASA 1 or 2. A dose-response curve for Org 9426 was constructed and the ED90, mean (SD), was found to be 0.36 (0.031) mg/kg. The onset of action was 3.8 (1.8) minutes, the clinical duration 17.4 (3.2) minutes, the total duration of action 31.9 (6.2) minutes and the recovery time 9.96 (3.2) minutes. No signs of histamine release or cardiovascular effects were observed. Org 9426 thus has a faster onset of action than vecuronium bromide or atracurium dibesylate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035776     DOI: 10.1111/j.1365-2044.1991.tb09539.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  6 in total

Review 1.  Clinical pharmacokinetics of rocuronium bromide.

Authors:  K S Khuenl-Brady; H Sparr
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 2.  Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  M Abel; W J Book; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 3.  Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

4.  Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium.

Authors:  E P McCoy; V R Maddineni; P Elliott; R K Mirakhur; I W Carson; R A Cooper
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

Review 5.  Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.

Authors:  R K Mirakhur
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

6.  Preliminary investigations of the clinical pharmacology of three short-acting non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489 and Org 9487.

Authors:  J M Wierda; A M Beaufort; U W Kleef; N J Smeulers; S Agoston
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.